“Inflammasomes As a Prognostic Marker and Possible Therapeutic Target in Multiple Sclerosis: A Rapid Review of the Literature”. Principles and Practice of Clinical Research, vol. 9, no. 2, Sept. 2023, https://doi.org/10.21801/ppcrj.2023.92.7.